IMW 2019 | The impact of renal impairment on the MM treatment strategy

Katja Weisel

Katja Weisel, MD, of University Medical Center Hamburg-Eppendorf, Hamburg, Germany, explains how renal impairment impacts the multiple myeloma (MM) treatment strategy at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video